Omicron
Showing 1 - 25 of 229
Coronavirus Trial (Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells), Recombinant novel
Not yet recruiting
- Coronavirus
- Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)
- Recombinant novel coronavirus protein vaccine (CHO cells)
- (no location specified)
Sep 5, 2023
COVID-19 Trial (Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells), Placebo)
Not yet recruiting
- COVID-19
- Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)
- Placebo
- (no location specified)
Sep 22, 2023
Postoperative Complications, Morality Trial in Xi'an (In-Hospital COVID-19 Omicron Infection after surgery)
Completed
- Postoperative Complications
- Morality
- In-Hospital COVID-19 Omicron Infection after surgery
-
Xi'an, Shannxi, ChinaThe Second Affiliated Hospital of Air Force Medical University U
Sep 8, 2023
Omicron Variant of COVID-19 Trial in Wenzhou (Nirmatrelvir/Ritonavir)
Completed
- Omicron Variant of COVID-19
-
Wenzhou, Zhejiang, ChinaXiangao Jiang
Apr 12, 2023
COVID-19 Trial (NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine, Prototype/XBB.1.5 Bivalent Vaccine (5 µg))
Not yet recruiting
- COVID-19
- NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine
- Prototype/XBB.1.5 Bivalent Vaccine (5 µg)
- (no location specified)
Aug 4, 2023
Coronavirus Trial in Wuhu (Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells), Recombinant
Active, not recruiting
- Coronavirus
- Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)
- Recombinant novel coronavirus protein vaccine (CHO cells)
-
Wuhu, Anhui, ChinaWannan Medical College Yijishan Hospital
May 6, 2023
SARS-CoV-2 Trial (SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine low dose, SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine high
Not yet recruiting
- SARS-CoV-2
- SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine low dose
- +2 more
- (no location specified)
Dec 1, 2022
Acupuncture, Covid-19 Omicron, Pulmonary Function Trial in Changsha (Acupuncture)
Recruiting
- Acupuncture
- +2 more
- Acupuncture
-
Changsha, Hunan, ChinaThe First Affiliated Hospital of Hunan University of Chinese Med
Jan 19, 2023
SARS-CoV-2 Trial in Bengbu (SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine Low dose, SARS-CoV-2 Variant (Omicron BA.5) mRNA
Active, not recruiting
- SARS-CoV-2
- SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine Low dose
- +2 more
-
Bengbu, Anhui, ChinaFirst Affiliated Hospital Bengbu Medical College
Jan 3, 2023
COVID-19, Influenza, Vaccine Reaction Trial in Seoul, Incheon (Omicron-containing COVID-19 vaccine, influenza vaccine)
Recruiting
- COVID-19
- +3 more
- Omicron-containing COVID-19 vaccine
- influenza vaccine
-
Seoul, Guro-gu, Korea, Republic of
- +1 more
Oct 17, 2023
Lianhua Qingwen in Treating Patients Infected With Omicron
Not yet recruiting
- COVID-19 Pneumonia
- The group of patients who received Lianhua Qingwen orally
- The group of patients who did not receive Lianhua Qingwen orally
- (no location specified)
Mar 20, 2023
Viral Excretion Among COVID-19 Omicron Recurrence Patients
Recruiting
- COVID-19 Recurrence
- Surface Contamination
- COVID-19 Omicron Recurrence
-
Shanghai, ChinaRenji Hospital
Jul 20, 2022
COVID-19 Trial (Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 3 microgram dose, Bivalent BNT162b2 (original/Omicron BA.4/BA.5)
Not yet recruiting
- COVID-19
- Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 3 microgram dose
- +3 more
- (no location specified)
Dec 22, 2022
COVID-19, Vaccines Trial in Santiago (CoronaVac®, Omicron Vaccine, Trivalent Vaccine)
Recruiting
- COVID-19
- Vaccines
- CoronaVac®
- +2 more
-
Santiago, Metropolitana, Chile
- +2 more
Jan 12, 2023
COVID-19 Trial in Huai'an (COVID-19 Vaccine (Vero cell), Inactivated (Omicron variant), COVID-19 Vaccine (Vero cell),
Recruiting
- COVID-19
- COVID-19 Vaccine (Vero cell), Inactivated (Omicron variant)
- COVID-19 Vaccine (Vero cell), Inactivated (CZ strain)
-
Huai'an, Jiangsu, ChinaHuaiyin Center for Disease Control and Prevention
Jan 11, 2023
SARS-CoV-2 Trial in Bengbu (SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine, Saline solution)
Recruiting
- SARS-CoV-2
- SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine
- Saline solution
-
Bengbu, Anhui, ChinaFirst Affiliated Hospital Bengbu Medical College
Feb 26, 2023
COVID-19 Trial in Bengbu (Recombinant Omicron-Delta COVID-19 Vaccine (CHO Cell), Inactivated COVID-19 vaccine (Vero Cell))
Active, not recruiting
- COVID-19
- Recombinant Omicron-Delta COVID-19 Vaccine (CHO Cell)
- Inactivated COVID-19 vaccine (Vero Cell)
-
Bengbu, Anhui, ChinaThe First Affiliated Hospital of Bengbu Medical College
Nov 3, 2022
Coronavirus, Traditional Chinese Medicine Trial in Urumqi (Lianhua Qingke tablets)
Recruiting
- Coronavirus
- Traditional Chinese Medicine
- Lianhua Qingke tablets
-
Urumqi, Xinjiang, ChinaInternational Convention and Exhibition Center Shelter Hospital
Nov 14, 2022
SARS-CoV-2 Virus, Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19 Trial (Bivalent BNT162b2 (original/Omicron
Not yet recruiting
- SARS-CoV-2 Virus
- +2 more
- Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 3 microgram dose
- +4 more
- (no location specified)
Sep 14, 2022
Viral Dynamics of Omicron in Children
Completed
- SARS-CoV2 Infection, COVID-19
- Daily SARS-CoV-2 PCR Testing for 10 days
-
Toronto, Ontario, CanadaThe Hospital for Sick Children
Nov 25, 2022
COVID-19 Trial in Wong Chuk Hang (COVID-19 Vaccine (Vero Cell), Inactivated, Omicron Strain)
Recruiting
- COVID-19
- COVID-19 Vaccine (Vero Cell), Inactivated, Omicron Strain
-
Wong Chuk Hang, HongKong, ChinaGleneagles Hospital HongKong
Jul 4, 2022
Hemodialysis Patients With Omicron Infection
Completed
- COVID-19
- no intervention
-
Shanghai, Shanghai, ChinaRenji Hospital, School of Medicine, Shanghai Jiaotong University
Sep 26, 2022
COVID-19 Pandemic, Immunogenicity, SARS CoV 2 Infection Trial in Ramat-Gan (mRNA-1273.214 Vaccine, MRNA-1273 Vaccine, Placebo)
Recruiting
- COVID-19 Pandemic
- +3 more
- mRNA-1273.214 Vaccine
- +2 more
-
Ramat-Gan, IsraelSheba Medical Center
Oct 26, 2022
Vaccine Reaction, COVID-19 Trial in Paris (Comirnaty® BNT162b2 /Omicron BA.4-5 vaccine (Pfizer-BioNTech), VidPrevtyn® Beta
Not yet recruiting
- Vaccine Reaction
- COVID-19
- Comirnaty® BNT162b2 /Omicron BA.4-5 vaccine (Pfizer-BioNTech)
- VidPrevtyn® Beta vaccine (Sanofi/GSK)
-
Paris, FranceCIC 1417 Cochin-Pasteur
Feb 28, 2023
Moderna COVID-19 Bivalent Booster for Omicron BA.4/5
Recruiting
- COVID-19
- Moderna COVID-19 Vaccine
- +3 more
-
Culver City, CaliforniaScience37
Mar 9, 2023